nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR1B—dura mater—bone cancer	0.0449	0.181	CbGeAlD
Pramipexole—HTR1D—dura mater—bone cancer	0.0435	0.175	CbGeAlD
Pramipexole—DRD5—eyelid—bone cancer	0.0428	0.172	CbGeAlD
Pramipexole—HTR1B—trigeminal nerve—bone cancer	0.0193	0.0777	CbGeAlD
Pramipexole—HTR1D—trigeminal nerve—bone cancer	0.0187	0.0753	CbGeAlD
Pramipexole—HTR1B—cranial nerve—bone cancer	0.0138	0.0554	CbGeAlD
Pramipexole—HTR1D—cranial nerve—bone cancer	0.0133	0.0536	CbGeAlD
Pramipexole—HTR2A—trigeminal nerve—bone cancer	0.00929	0.0374	CbGeAlD
Pramipexole—HTR2A—cranial nerve—bone cancer	0.00662	0.0266	CbGeAlD
Pramipexole—HTR2A—vertebral column—bone cancer	0.00649	0.0261	CbGeAlD
Pramipexole—HTR2A—hindlimb—bone cancer	0.00558	0.0225	CbGeAlD
Pramipexole—HTR2A—appendage—bone cancer	0.00479	0.0193	CbGeAlD
Pramipexole—HTR1D—connective tissue—bone cancer	0.00275	0.0111	CbGeAlD
Pramipexole—HTR1B—spinal cord—bone cancer	0.00188	0.00758	CbGeAlD
Pramipexole—HTR2C—spinal cord—bone cancer	0.00181	0.00726	CbGeAlD
Pramipexole—HTR2B—tendon—bone cancer	0.00176	0.00708	CbGeAlD
Pramipexole—ADRA2A—connective tissue—bone cancer	0.00161	0.00647	CbGeAlD
Pramipexole—HTR1A—spinal cord—bone cancer	0.00152	0.00611	CbGeAlD
Pramipexole—ADRA2C—tendon—bone cancer	0.00138	0.00557	CbGeAlD
Pramipexole—HTR2A—connective tissue—bone cancer	0.00137	0.0055	CbGeAlD
Pramipexole—ADRA2C—spinal cord—bone cancer	0.00133	0.00537	CbGeAlD
Pramipexole—ADRA2A—tendon—bone cancer	0.0011	0.00444	CbGeAlD
Pramipexole—ADRA2A—spinal cord—bone cancer	0.00107	0.00429	CbGeAlD
Pramipexole—HTR2A—tendon—bone cancer	0.000939	0.00378	CbGeAlD
Pramipexole—HTR2A—spinal cord—bone cancer	0.000906	0.00364	CbGeAlD
Pramipexole—Sinusitis—Epirubicin—bone cancer	0.000479	0.000698	CcSEcCtD
Pramipexole—Hyperglycaemia—Doxorubicin—bone cancer	0.000478	0.000697	CcSEcCtD
Pramipexole—Pneumonia—Doxorubicin—bone cancer	0.000476	0.000693	CcSEcCtD
Pramipexole—Infestation—Doxorubicin—bone cancer	0.000473	0.000689	CcSEcCtD
Pramipexole—Infestation NOS—Doxorubicin—bone cancer	0.000473	0.000689	CcSEcCtD
Pramipexole—Drowsiness—Doxorubicin—bone cancer	0.000473	0.000689	CcSEcCtD
Pramipexole—Visual impairment—Methotrexate—bone cancer	0.000472	0.000688	CcSEcCtD
Pramipexole—Hypersensitivity—Cisplatin—bone cancer	0.000468	0.000681	CcSEcCtD
Pramipexole—Bradycardia—Epirubicin—bone cancer	0.000467	0.00068	CcSEcCtD
Pramipexole—Renal failure—Doxorubicin—bone cancer	0.000465	0.000677	CcSEcCtD
Pramipexole—Neuropathy peripheral—Doxorubicin—bone cancer	0.000463	0.000675	CcSEcCtD
Pramipexole—Rhinitis—Epirubicin—bone cancer	0.00046	0.00067	CcSEcCtD
Pramipexole—Conjunctivitis—Doxorubicin—bone cancer	0.00046	0.00067	CcSEcCtD
Pramipexole—Urinary tract infection—Doxorubicin—bone cancer	0.00046	0.00067	CcSEcCtD
Pramipexole—Eye disorder—Methotrexate—bone cancer	0.000458	0.000667	CcSEcCtD
Pramipexole—Tinnitus—Methotrexate—bone cancer	0.000457	0.000666	CcSEcCtD
Pramipexole—Hypoaesthesia—Epirubicin—bone cancer	0.000456	0.000665	CcSEcCtD
Pramipexole—Asthenia—Cisplatin—bone cancer	0.000455	0.000663	CcSEcCtD
Pramipexole—Pharyngitis—Epirubicin—bone cancer	0.000455	0.000663	CcSEcCtD
Pramipexole—Cardiac disorder—Methotrexate—bone cancer	0.000455	0.000663	CcSEcCtD
Pramipexole—Sweating—Doxorubicin—bone cancer	0.000453	0.00066	CcSEcCtD
Pramipexole—Urinary tract disorder—Epirubicin—bone cancer	0.000453	0.00066	CcSEcCtD
Pramipexole—Oedema peripheral—Epirubicin—bone cancer	0.000452	0.000658	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—bone cancer	0.000451	0.000657	CcSEcCtD
Pramipexole—Connective tissue disorder—Epirubicin—bone cancer	0.000451	0.000657	CcSEcCtD
Pramipexole—Urethral disorder—Epirubicin—bone cancer	0.00045	0.000655	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—bone cancer	0.000447	0.000651	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—bone cancer	0.000446	0.00065	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—bone cancer	0.000445	0.000648	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—bone cancer	0.000444	0.000646	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—bone cancer	0.000443	0.000645	CcSEcCtD
Pramipexole—Visual impairment—Epirubicin—bone cancer	0.000442	0.000644	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—bone cancer	0.000442	0.000644	CcSEcCtD
Pramipexole—Chills—Methotrexate—bone cancer	0.00044	0.000641	CcSEcCtD
Pramipexole—Diarrhoea—Cisplatin—bone cancer	0.000434	0.000633	CcSEcCtD
Pramipexole—Alopecia—Methotrexate—bone cancer	0.000433	0.000631	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—bone cancer	0.000432	0.00063	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—bone cancer	0.000429	0.000626	CcSEcCtD
Pramipexole—Eye disorder—Epirubicin—bone cancer	0.000429	0.000625	CcSEcCtD
Pramipexole—Tinnitus—Epirubicin—bone cancer	0.000428	0.000623	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—bone cancer	0.000427	0.000622	CcSEcCtD
Pramipexole—Erythema—Methotrexate—bone cancer	0.000427	0.000622	CcSEcCtD
Pramipexole—Cardiac disorder—Epirubicin—bone cancer	0.000426	0.00062	CcSEcCtD
Pramipexole—Flushing—Epirubicin—bone cancer	0.000426	0.00062	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—bone cancer	0.000425	0.00062	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—bone cancer	0.000422	0.000615	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—bone cancer	0.000421	0.000614	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—bone cancer	0.000419	0.000611	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—bone cancer	0.000418	0.000609	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—bone cancer	0.000418	0.000609	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—bone cancer	0.000417	0.000608	CcSEcCtD
Pramipexole—Angiopathy—Epirubicin—bone cancer	0.000416	0.000606	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—bone cancer	0.000416	0.000606	CcSEcCtD
Pramipexole—Immune system disorder—Epirubicin—bone cancer	0.000414	0.000604	CcSEcCtD
Pramipexole—Mediastinal disorder—Epirubicin—bone cancer	0.000413	0.000602	CcSEcCtD
Pramipexole—Back pain—Methotrexate—bone cancer	0.000413	0.000601	CcSEcCtD
Pramipexole—Chills—Epirubicin—bone cancer	0.000412	0.0006	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—bone cancer	0.000409	0.000596	CcSEcCtD
Pramipexole—Alopecia—Epirubicin—bone cancer	0.000405	0.000591	CcSEcCtD
Pramipexole—Vomiting—Cisplatin—bone cancer	0.000403	0.000588	CcSEcCtD
Pramipexole—Vision blurred—Methotrexate—bone cancer	0.000402	0.000586	CcSEcCtD
Pramipexole—Mental disorder—Epirubicin—bone cancer	0.000402	0.000585	CcSEcCtD
Pramipexole—Rash—Cisplatin—bone cancer	0.0004	0.000583	CcSEcCtD
Pramipexole—Dermatitis—Cisplatin—bone cancer	0.0004	0.000582	CcSEcCtD
Pramipexole—Malnutrition—Epirubicin—bone cancer	0.000399	0.000582	CcSEcCtD
Pramipexole—Erythema—Epirubicin—bone cancer	0.000399	0.000582	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—bone cancer	0.000397	0.000578	CcSEcCtD
Pramipexole—Ill-defined disorder—Methotrexate—bone cancer	0.000396	0.000577	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—bone cancer	0.000396	0.000577	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—bone cancer	0.000394	0.000575	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—bone cancer	0.000394	0.000574	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—bone cancer	0.000394	0.000574	CcSEcCtD
Pramipexole—Flatulence—Epirubicin—bone cancer	0.000393	0.000573	CcSEcCtD
Pramipexole—Tension—Epirubicin—bone cancer	0.000392	0.000571	CcSEcCtD
Pramipexole—Dysgeusia—Epirubicin—bone cancer	0.000391	0.00057	CcSEcCtD
Pramipexole—Nervousness—Epirubicin—bone cancer	0.000388	0.000565	CcSEcCtD
Pramipexole—Back pain—Epirubicin—bone cancer	0.000386	0.000563	CcSEcCtD
Pramipexole—Angiopathy—Doxorubicin—bone cancer	0.000385	0.000561	CcSEcCtD
Pramipexole—Malaise—Methotrexate—bone cancer	0.000385	0.000561	CcSEcCtD
Pramipexole—Muscle spasms—Epirubicin—bone cancer	0.000384	0.000559	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—bone cancer	0.000383	0.000559	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—bone cancer	0.000383	0.000559	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—bone cancer	0.000382	0.000557	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—bone cancer	0.000382	0.000556	CcSEcCtD
Pramipexole—Chills—Doxorubicin—bone cancer	0.000381	0.000555	CcSEcCtD
Pramipexole—Nausea—Cisplatin—bone cancer	0.000377	0.000549	CcSEcCtD
Pramipexole—Vision blurred—Epirubicin—bone cancer	0.000376	0.000548	CcSEcCtD
Pramipexole—Alopecia—Doxorubicin—bone cancer	0.000375	0.000546	CcSEcCtD
Pramipexole—Cough—Methotrexate—bone cancer	0.000372	0.000542	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—bone cancer	0.000372	0.000542	CcSEcCtD
Pramipexole—Ill-defined disorder—Epirubicin—bone cancer	0.00037	0.00054	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—bone cancer	0.00037	0.000539	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—bone cancer	0.000369	0.000538	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—bone cancer	0.000369	0.000538	CcSEcCtD
Pramipexole—Anaemia—Epirubicin—bone cancer	0.000369	0.000538	CcSEcCtD
Pramipexole—Agitation—Epirubicin—bone cancer	0.000367	0.000535	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—bone cancer	0.000364	0.00053	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—bone cancer	0.000363	0.000529	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—bone cancer	0.000363	0.000529	CcSEcCtD
Pramipexole—Chest pain—Methotrexate—bone cancer	0.000363	0.000529	CcSEcCtD
Pramipexole—Tension—Doxorubicin—bone cancer	0.000363	0.000528	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—bone cancer	0.000362	0.000527	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000361	0.000526	CcSEcCtD
Pramipexole—Malaise—Epirubicin—bone cancer	0.00036	0.000525	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—bone cancer	0.000359	0.000523	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—bone cancer	0.000359	0.000523	CcSEcCtD
Pramipexole—Vertigo—Epirubicin—bone cancer	0.000359	0.000523	CcSEcCtD
Pramipexole—Syncope—Epirubicin—bone cancer	0.000358	0.000522	CcSEcCtD
Pramipexole—Leukopenia—Epirubicin—bone cancer	0.000357	0.000521	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—bone cancer	0.000357	0.000521	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—bone cancer	0.000355	0.000518	CcSEcCtD
Pramipexole—Palpitations—Epirubicin—bone cancer	0.000353	0.000514	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—bone cancer	0.000351	0.000512	CcSEcCtD
Pramipexole—Loss of consciousness—Epirubicin—bone cancer	0.000351	0.000511	CcSEcCtD
Pramipexole—Cough—Epirubicin—bone cancer	0.000348	0.000508	CcSEcCtD
Pramipexole—Vision blurred—Doxorubicin—bone cancer	0.000348	0.000507	CcSEcCtD
Pramipexole—Convulsion—Epirubicin—bone cancer	0.000346	0.000504	CcSEcCtD
Pramipexole—Infection—Methotrexate—bone cancer	0.000346	0.000504	CcSEcCtD
Pramipexole—Hypertension—Epirubicin—bone cancer	0.000345	0.000502	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—bone cancer	0.000343	0.000499	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—bone cancer	0.000341	0.000498	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—bone cancer	0.000341	0.000498	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—bone cancer	0.000341	0.000497	CcSEcCtD
Pramipexole—Chest pain—Epirubicin—bone cancer	0.00034	0.000495	CcSEcCtD
Pramipexole—Arthralgia—Epirubicin—bone cancer	0.00034	0.000495	CcSEcCtD
Pramipexole—Myalgia—Epirubicin—bone cancer	0.00034	0.000495	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—bone cancer	0.00034	0.000495	CcSEcCtD
Pramipexole—Anxiety—Epirubicin—bone cancer	0.000339	0.000494	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—bone cancer	0.000338	0.000493	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000338	0.000492	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—bone cancer	0.000337	0.00049	CcSEcCtD
Pramipexole—Discomfort—Epirubicin—bone cancer	0.000336	0.000489	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—bone cancer	0.000333	0.000485	CcSEcCtD
Pramipexole—Dry mouth—Epirubicin—bone cancer	0.000332	0.000484	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—bone cancer	0.000332	0.000484	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—bone cancer	0.000332	0.000484	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—bone cancer	0.000331	0.000483	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—bone cancer	0.000331	0.000482	CcSEcCtD
Pramipexole—Confusional state—Epirubicin—bone cancer	0.000329	0.000479	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—bone cancer	0.000326	0.000476	CcSEcCtD
Pramipexole—Oedema—Epirubicin—bone cancer	0.000326	0.000475	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—bone cancer	0.000325	0.000474	CcSEcCtD
Pramipexole—Loss of consciousness—Doxorubicin—bone cancer	0.000325	0.000473	CcSEcCtD
Pramipexole—Infection—Epirubicin—bone cancer	0.000324	0.000472	CcSEcCtD
Pramipexole—Cough—Doxorubicin—bone cancer	0.000322	0.00047	CcSEcCtD
Pramipexole—Shock—Epirubicin—bone cancer	0.000321	0.000467	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—bone cancer	0.00032	0.000466	CcSEcCtD
Pramipexole—Nervous system disorder—Epirubicin—bone cancer	0.00032	0.000466	CcSEcCtD
Pramipexole—Thrombocytopenia—Epirubicin—bone cancer	0.000319	0.000465	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—bone cancer	0.000319	0.000465	CcSEcCtD
Pramipexole—Tachycardia—Epirubicin—bone cancer	0.000318	0.000463	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000317	0.000462	CcSEcCtD
Pramipexole—Skin disorder—Epirubicin—bone cancer	0.000317	0.000461	CcSEcCtD
Pramipexole—Hyperhidrosis—Epirubicin—bone cancer	0.000315	0.000459	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—bone cancer	0.000315	0.000459	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—bone cancer	0.000315	0.000458	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—bone cancer	0.000315	0.000458	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—bone cancer	0.000315	0.000458	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—bone cancer	0.000313	0.000457	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—bone cancer	0.000313	0.000456	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000312	0.000455	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—bone cancer	0.000311	0.000453	CcSEcCtD
Pramipexole—Anorexia—Epirubicin—bone cancer	0.000311	0.000453	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—bone cancer	0.00031	0.000452	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—bone cancer	0.00031	0.000451	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—bone cancer	0.000308	0.000448	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—bone cancer	0.000307	0.000447	CcSEcCtD
Pramipexole—Hypotension—Epirubicin—bone cancer	0.000305	0.000444	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—bone cancer	0.000304	0.000443	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—bone cancer	0.000303	0.000441	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—bone cancer	0.000302	0.000439	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000301	0.000438	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—bone cancer	0.0003	0.000437	CcSEcCtD
Pramipexole—Infection—Doxorubicin—bone cancer	0.0003	0.000436	CcSEcCtD
Pramipexole—Pain—Methotrexate—bone cancer	0.000298	0.000434	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000297	0.000433	CcSEcCtD
Pramipexole—Shock—Doxorubicin—bone cancer	0.000297	0.000432	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—bone cancer	0.000296	0.000431	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—bone cancer	0.000295	0.00043	CcSEcCtD
Pramipexole—Insomnia—Epirubicin—bone cancer	0.000295	0.000429	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—bone cancer	0.000294	0.000429	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—bone cancer	0.000293	0.000427	CcSEcCtD
Pramipexole—Paraesthesia—Epirubicin—bone cancer	0.000293	0.000426	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—bone cancer	0.000291	0.000425	CcSEcCtD
Pramipexole—Dyspnoea—Epirubicin—bone cancer	0.000291	0.000423	CcSEcCtD
Pramipexole—Somnolence—Epirubicin—bone cancer	0.00029	0.000422	CcSEcCtD
Pramipexole—Anorexia—Doxorubicin—bone cancer	0.000287	0.000419	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—bone cancer	0.000287	0.000418	CcSEcCtD
Pramipexole—Dyspepsia—Epirubicin—bone cancer	0.000287	0.000418	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—bone cancer	0.000285	0.000415	CcSEcCtD
Pramipexole—Decreased appetite—Epirubicin—bone cancer	0.000283	0.000413	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—bone cancer	0.000282	0.000411	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000281	0.00041	CcSEcCtD
Pramipexole—Fatigue—Epirubicin—bone cancer	0.000281	0.000409	CcSEcCtD
Pramipexole—Pain—Epirubicin—bone cancer	0.000279	0.000406	CcSEcCtD
Pramipexole—Constipation—Epirubicin—bone cancer	0.000279	0.000406	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—bone cancer	0.000277	0.000403	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—bone cancer	0.000275	0.000401	CcSEcCtD
Pramipexole—Body temperature increased—Methotrexate—bone cancer	0.000275	0.000401	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000275	0.0004	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—bone cancer	0.000273	0.000397	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—bone cancer	0.000271	0.000394	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—bone cancer	0.000269	0.000392	CcSEcCtD
Pramipexole—Feeling abnormal—Epirubicin—bone cancer	0.000269	0.000391	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—bone cancer	0.000268	0.000391	CcSEcCtD
Pramipexole—Gastrointestinal pain—Epirubicin—bone cancer	0.000266	0.000388	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—bone cancer	0.000265	0.000387	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—bone cancer	0.000262	0.000382	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00026	0.000379	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—bone cancer	0.00026	0.000379	CcSEcCtD
Pramipexole—Urticaria—Epirubicin—bone cancer	0.000259	0.000377	CcSEcCtD
Pramipexole—Pain—Doxorubicin—bone cancer	0.000258	0.000376	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—bone cancer	0.000258	0.000376	CcSEcCtD
Pramipexole—Body temperature increased—Epirubicin—bone cancer	0.000258	0.000375	CcSEcCtD
Pramipexole—Abdominal pain—Epirubicin—bone cancer	0.000258	0.000375	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—bone cancer	0.000257	0.000374	CcSEcCtD
Pramipexole—Asthenia—Methotrexate—bone cancer	0.00025	0.000364	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—bone cancer	0.000248	0.000362	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000247	0.000359	CcSEcCtD
Pramipexole—Pruritus—Methotrexate—bone cancer	0.000246	0.000359	CcSEcCtD
Pramipexole—Hypersensitivity—Epirubicin—bone cancer	0.00024	0.00035	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—bone cancer	0.00024	0.000349	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—bone cancer	0.000238	0.000347	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—bone cancer	0.000238	0.000347	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—bone cancer	0.000238	0.000347	CcSEcCtD
Pramipexole—Asthenia—Epirubicin—bone cancer	0.000234	0.000341	CcSEcCtD
Pramipexole—Pruritus—Epirubicin—bone cancer	0.000231	0.000336	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—bone cancer	0.00023	0.000336	CcSEcCtD
Pramipexole—Diarrhoea—Epirubicin—bone cancer	0.000223	0.000325	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—bone cancer	0.000222	0.000324	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—bone cancer	0.000221	0.000323	CcSEcCtD
Pramipexole—Rash—Methotrexate—bone cancer	0.00022	0.00032	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—bone cancer	0.000219	0.00032	CcSEcCtD
Pramipexole—Headache—Methotrexate—bone cancer	0.000218	0.000318	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—bone cancer	0.000216	0.000315	CcSEcCtD
Pramipexole—Dizziness—Epirubicin—bone cancer	0.000215	0.000314	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—bone cancer	0.000213	0.000311	CcSEcCtD
Pramipexole—Vomiting—Epirubicin—bone cancer	0.000207	0.000302	CcSEcCtD
Pramipexole—Nausea—Methotrexate—bone cancer	0.000207	0.000301	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—bone cancer	0.000206	0.000301	CcSEcCtD
Pramipexole—Rash—Epirubicin—bone cancer	0.000205	0.000299	CcSEcCtD
Pramipexole—Dermatitis—Epirubicin—bone cancer	0.000205	0.000299	CcSEcCtD
Pramipexole—Headache—Epirubicin—bone cancer	0.000204	0.000297	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—bone cancer	0.000199	0.000291	CcSEcCtD
Pramipexole—Nausea—Epirubicin—bone cancer	0.000194	0.000282	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—bone cancer	0.000192	0.000279	CcSEcCtD
Pramipexole—Rash—Doxorubicin—bone cancer	0.00019	0.000277	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—bone cancer	0.00019	0.000277	CcSEcCtD
Pramipexole—Headache—Doxorubicin—bone cancer	0.000189	0.000275	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—bone cancer	0.000179	0.000261	CcSEcCtD
Pramipexole—ADRA2B—Signaling by GPCR—IL3—bone cancer	5.6e-05	0.000859	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL3—bone cancer	5.59e-05	0.000858	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GRM4—bone cancer	5.54e-05	0.000849	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RGS1—bone cancer	5.54e-05	0.000849	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—GRM1—bone cancer	5.47e-05	0.000839	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GRM4—bone cancer	5.45e-05	0.000836	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RGS1—bone cancer	5.45e-05	0.000836	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—GRM1—bone cancer	5.44e-05	0.000834	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL3—bone cancer	5.41e-05	0.000829	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL3—bone cancer	5.38e-05	0.000825	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—GRM1—bone cancer	5.29e-05	0.000812	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—GNA11—bone cancer	5.24e-05	0.000803	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL3—bone cancer	5.23e-05	0.000803	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—IL3—bone cancer	5.23e-05	0.000802	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SMO—bone cancer	5.16e-05	0.000792	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	5.16e-05	0.000792	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—GNA11—bone cancer	5.15e-05	0.00079	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—IL3—bone cancer	5.14e-05	0.000789	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—SMO—bone cancer	5.12e-05	0.000786	CbGpPWpGaD
Pramipexole—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	5.07e-05	0.000778	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SMO—bone cancer	5.06e-05	0.000776	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SMO—bone cancer	4.97e-05	0.000763	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RGS1—bone cancer	4.95e-05	0.00076	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GRM4—bone cancer	4.95e-05	0.00076	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—PLAU—bone cancer	4.86e-05	0.000745	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—ENO2—bone cancer	4.83e-05	0.000742	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GRM1—bone cancer	4.8e-05	0.000736	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFBR2—bone cancer	4.78e-05	0.000733	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SMO—bone cancer	4.75e-05	0.000729	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL3—bone cancer	4.75e-05	0.000728	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—GNA11—bone cancer	4.72e-05	0.000725	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GRM1—bone cancer	4.72e-05	0.000725	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—ENO2—bone cancer	4.7e-05	0.000721	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—GNA11—bone cancer	4.69e-05	0.000719	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL3—bone cancer	4.68e-05	0.000718	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL3—bone cancer	4.67e-05	0.000717	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—GNA11—bone cancer	4.62e-05	0.000709	CbGpPWpGaD
Pramipexole—DRD2—Circadian rythm related genes—TP53—bone cancer	4.56e-05	0.0007	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—GNA11—bone cancer	4.55e-05	0.000698	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—ENO2—bone cancer	4.51e-05	0.000691	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IGF1R—bone cancer	4.5e-05	0.00069	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—DHFR—bone cancer	4.48e-05	0.000688	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SMO—bone cancer	4.48e-05	0.000687	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SMO—bone cancer	4.42e-05	0.000678	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ATF1—bone cancer	4.39e-05	0.000674	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—DHFR—bone cancer	4.36e-05	0.000669	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—GNA11—bone cancer	4.34e-05	0.000666	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ATF1—bone cancer	4.3e-05	0.00066	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GRM1—bone cancer	4.3e-05	0.000659	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL3—bone cancer	4.28e-05	0.000657	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL3—bone cancer	4.25e-05	0.000652	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ATF1—bone cancer	4.23e-05	0.000649	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL3—bone cancer	4.19e-05	0.000643	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GNA11—bone cancer	4.19e-05	0.000643	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—DHFR—bone cancer	4.18e-05	0.000641	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL3—bone cancer	4.13e-05	0.000633	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—GNA11—bone cancer	4.1e-05	0.000629	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GNA11—bone cancer	4.08e-05	0.000625	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—GNA11—bone cancer	4.04e-05	0.00062	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ATF1—bone cancer	4.04e-05	0.00062	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SMO—bone cancer	3.99e-05	0.000612	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL3—bone cancer	3.94e-05	0.000604	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GNA11—bone cancer	3.91e-05	0.000599	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SMO—bone cancer	3.85e-05	0.000591	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SMO—bone cancer	3.83e-05	0.000588	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—ENO2—bone cancer	3.82e-05	0.000586	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ATF1—bone cancer	3.81e-05	0.000584	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—CYP3A4—bone cancer	3.8e-05	0.000583	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ATF1—bone cancer	3.76e-05	0.000577	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SMO—bone cancer	3.73e-05	0.000572	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL3—bone cancer	3.71e-05	0.00057	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—CYP3A4—bone cancer	3.7e-05	0.000567	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL3—bone cancer	3.66e-05	0.000562	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFBR2—bone cancer	3.66e-05	0.000562	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—GNA11—bone cancer	3.65e-05	0.00056	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFBR2—bone cancer	3.59e-05	0.00055	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—DHFR—bone cancer	3.54e-05	0.000544	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—CYP3A4—bone cancer	3.54e-05	0.000543	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFBR2—bone cancer	3.53e-05	0.000541	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—GNA11—bone cancer	3.52e-05	0.00054	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—GNA11—bone cancer	3.5e-05	0.000538	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IGF1R—bone cancer	3.44e-05	0.000529	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—GNA11—bone cancer	3.41e-05	0.000523	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ATF1—bone cancer	3.39e-05	0.000521	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SMO—bone cancer	3.38e-05	0.000519	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IGF1R—bone cancer	3.37e-05	0.000518	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFBR2—bone cancer	3.37e-05	0.000517	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SMO—bone cancer	3.33e-05	0.000511	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IGF1R—bone cancer	3.32e-05	0.000509	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GNA11—bone cancer	3.31e-05	0.000508	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL3—bone cancer	3.31e-05	0.000508	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ATF1—bone cancer	3.27e-05	0.000502	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—KIT—bone cancer	3.26e-05	0.0005	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ATF1—bone cancer	3.26e-05	0.0005	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—GSTP1—bone cancer	3.25e-05	0.000499	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL3—bone cancer	3.19e-05	0.00049	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL3—bone cancer	3.18e-05	0.000487	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFBR2—bone cancer	3.18e-05	0.000487	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ATF1—bone cancer	3.17e-05	0.000486	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IGF1R—bone cancer	3.17e-05	0.000486	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—GSTP1—bone cancer	3.16e-05	0.000485	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFBR2—bone cancer	3.13e-05	0.000481	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—GNA11—bone cancer	3.09e-05	0.000475	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL3—bone cancer	3.09e-05	0.000474	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—BRAF—bone cancer	3.07e-05	0.00047	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—GNA11—bone cancer	3.04e-05	0.000467	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—GSTP1—bone cancer	3.03e-05	0.000465	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SMO—bone cancer	3.03e-05	0.000464	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—CYP3A4—bone cancer	3e-05	0.000461	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IGF1R—bone cancer	2.99e-05	0.000459	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—EGFR—bone cancer	2.97e-05	0.000456	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IGF1R—bone cancer	2.95e-05	0.000452	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ATF1—bone cancer	2.88e-05	0.000441	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.83e-05	0.000434	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ATF1—bone cancer	2.83e-05	0.000434	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL3—bone cancer	2.8e-05	0.00043	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.77e-05	0.000425	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL3—bone cancer	2.76e-05	0.000423	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.73e-05	0.000419	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.72e-05	0.000417	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.66e-05	0.000408	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.64e-05	0.000406	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.57e-05	0.000395	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—bone cancer	2.57e-05	0.000395	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.57e-05	0.000394	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MDM2—bone cancer	2.57e-05	0.000394	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—GSTP1—bone cancer	2.57e-05	0.000394	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.56e-05	0.000392	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL3—bone cancer	2.51e-05	0.000385	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—KIT—bone cancer	2.5e-05	0.000383	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IGF1R—bone cancer	2.49e-05	0.000382	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—KIT—bone cancer	2.45e-05	0.000375	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—KIT—bone cancer	2.41e-05	0.000369	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—bone cancer	2.4e-05	0.000369	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.4e-05	0.000368	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.36e-05	0.000362	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—BRAF—bone cancer	2.35e-05	0.00036	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—BRAF—bone cancer	2.3e-05	0.000353	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—KIT—bone cancer	2.3e-05	0.000353	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—EGFR—bone cancer	2.28e-05	0.000349	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—BRAF—bone cancer	2.26e-05	0.000347	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IGF1R—bone cancer	2.26e-05	0.000346	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—JUN—bone cancer	2.23e-05	0.000343	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—EGFR—bone cancer	2.23e-05	0.000342	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.22e-05	0.000341	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—EGFR—bone cancer	2.19e-05	0.000337	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MMP9—bone cancer	2.17e-05	0.000333	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—KIT—bone cancer	2.17e-05	0.000333	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—BRAF—bone cancer	2.16e-05	0.000331	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2.15e-05	0.000329	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—KIT—bone cancer	2.14e-05	0.000328	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—EGFR—bone cancer	2.09e-05	0.000321	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—BRAF—bone cancer	2.04e-05	0.000313	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IGF1R—bone cancer	2.02e-05	0.00031	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—BRAF—bone cancer	2.01e-05	0.000308	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—EGFR—bone cancer	1.97e-05	0.000303	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MDM2—bone cancer	1.97e-05	0.000302	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—bone cancer	1.95e-05	0.0003	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EGFR—bone cancer	1.95e-05	0.000299	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—KIT—bone cancer	1.93e-05	0.000296	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MDM2—bone cancer	1.93e-05	0.000296	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MDM2—bone cancer	1.9e-05	0.000291	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—KIT—bone cancer	1.86e-05	0.000286	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—KIT—bone cancer	1.85e-05	0.000284	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.81e-05	0.000278	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MDM2—bone cancer	1.81e-05	0.000278	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—KIT—bone cancer	1.8e-05	0.000277	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.76e-05	0.00027	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EGFR—bone cancer	1.76e-05	0.000269	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—BRAF—bone cancer	1.75e-05	0.000269	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—BRAF—bone cancer	1.74e-05	0.000267	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—JUN—bone cancer	1.71e-05	0.000262	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MDM2—bone cancer	1.71e-05	0.000262	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.7e-05	0.000261	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.7e-05	0.00026	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.69e-05	0.000259	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MDM2—bone cancer	1.68e-05	0.000258	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PTGS2—bone cancer	1.68e-05	0.000258	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—JUN—bone cancer	1.67e-05	0.000257	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MMP9—bone cancer	1.66e-05	0.000255	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—JUN—bone cancer	1.65e-05	0.000253	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.64e-05	0.000252	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PTGS2—bone cancer	1.64e-05	0.000251	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—KIT—bone cancer	1.64e-05	0.000251	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MMP9—bone cancer	1.63e-05	0.00025	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—KIT—bone cancer	1.61e-05	0.000247	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MMP9—bone cancer	1.6e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—JUN—bone cancer	1.57e-05	0.000241	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PTGS2—bone cancer	1.57e-05	0.000241	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—BRAF—bone cancer	1.54e-05	0.000236	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MMP9—bone cancer	1.53e-05	0.000235	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.52e-05	0.000233	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—BRAF—bone cancer	1.51e-05	0.000232	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—bone cancer	1.49e-05	0.000229	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—JUN—bone cancer	1.48e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—bone cancer	1.47e-05	0.000226	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MDM2—bone cancer	1.47e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.47e-05	0.000225	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—KIT—bone cancer	1.46e-05	0.000225	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—JUN—bone cancer	1.46e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MDM2—bone cancer	1.46e-05	0.000224	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MMP9—bone cancer	1.44e-05	0.000221	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MMP9—bone cancer	1.42e-05	0.000219	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.42e-05	0.000218	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.38e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—bone cancer	1.34e-05	0.000206	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.33e-05	0.000205	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PTGS2—bone cancer	1.33e-05	0.000204	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—JUN—bone cancer	1.32e-05	0.000203	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—bone cancer	1.32e-05	0.000202	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—bone cancer	1.3e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MDM2—bone cancer	1.29e-05	0.000198	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.29e-05	0.000197	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—JUN—bone cancer	1.28e-05	0.000196	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—JUN—bone cancer	1.27e-05	0.000195	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MDM2—bone cancer	1.27e-05	0.000195	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MMP9—bone cancer	1.24e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—bone cancer	1.24e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MMP9—bone cancer	1.23e-05	0.000189	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—JUN—bone cancer	1.23e-05	0.000189	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.2e-05	0.000184	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—bone cancer	1.17e-05	0.000179	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.15e-05	0.000177	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—bone cancer	1.15e-05	0.000177	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—bone cancer	1.13e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—JUN—bone cancer	1.12e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—bone cancer	1.11e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—JUN—bone cancer	1.1e-05	0.000169	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MMP9—bone cancer	1.09e-05	0.000167	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—bone cancer	1.09e-05	0.000167	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MMP9—bone cancer	1.07e-05	0.000165	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—bone cancer	1.04e-05	0.000159	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—bone cancer	1.04e-05	0.000159	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—bone cancer	1e-05	0.000154	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—JUN—bone cancer	1e-05	0.000154	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—bone cancer	9.98e-06	0.000153	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—bone cancer	9.79e-06	0.00015	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MMP9—bone cancer	9.76e-06	0.00015	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—bone cancer	9.71e-06	0.000149	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—bone cancer	9.66e-06	0.000148	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—bone cancer	8.81e-06	0.000135	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—bone cancer	8.72e-06	0.000134	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—bone cancer	8.66e-06	0.000133	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—bone cancer	8.42e-06	0.000129	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—bone cancer	8.38e-06	0.000129	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—bone cancer	8.15e-06	0.000125	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—bone cancer	7.88e-06	0.000121	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—bone cancer	7.39e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—bone cancer	7.28e-06	0.000112	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—bone cancer	6.62e-06	0.000102	CbGpPWpGaD
